Search Results - Markqayne Ray
- Showing 1 - 4 results of 4
-
1
P1694: COST-EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL VS. TISAGENLECLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: UPDATED SURVIVAL RESULTS FROM THE ZUMA-1 A... by Olalekan Oluwole, Markqayne Ray, Neil Davies, Rory Bradford, Calum Jones, Anik Patel, Frederick Locke
Published in HemaSphere (2023-08-01)Get full text
Article -
2
A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States by Anik R. Patel, Bradley Kievit, Ken Hasegawa, Markqayne Ray, Rishika Sharma, Sarahmaria Hofmann, Rob Blissett, Frederick L. Locke
Published in MDM Policy & Practice (2025-06-01)Get full text
Article -
3
Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata by Markqayne Ray, Elyse Swallow, Kavita Gandhi, Christopher Carley, Vanja Sikirica, Travis Wang, Nicolae Done, James Signorovitch, Arash Mostaghimi
Published in Journal of Health Economics and Outcomes Research (2022-07-01)Get full text
Article -
4
Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil,... by John G. Gribben, Emmanuel Bachy, Markqayne Ray, Kathryn Krupsky, Kathleen Beusterien, Lewis Kopenhafer, Sara Beygi, Timothy Best, Graeme Ball, Oliver Will, Madhu Palivela, Anik Patel, Paola Ghione
Published in Frontiers in Oncology (2025-07-01)Get full text
Article
